Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 513

1.

Multicomponent assemblies in DNA-double-strand break repair by NHEJ.

Hnízda A, Blundell TL.

Curr Opin Struct Biol. 2019 May 21;55:154-160. doi: 10.1016/j.sbi.2019.03.026. [Epub ahead of print] Review.

PMID:
31125797
2.

Synthesis and Structure-Activity relationship of 1-(5-isoquinolinesulfonyl)piperazine analogues as inhibitors of Mycobacterium tuberculosis IMPDH.

Singh V, Pacitto A, Donini S, Ferraris DM, Boros S, Illyés E, Szokol B, Rizzi M, Blundell TL, Ascher DB, Pato J, Mizrahi V.

Eur J Med Chem. 2019 Jul 15;174:309-329. doi: 10.1016/j.ejmech.2019.04.027. Epub 2019 Apr 15.

PMID:
31055147
3.

Structure-guided fragment-based drug discovery at the synchrotron: screening binding sites and correlations with hotspot mapping.

Thomas SE, Collins P, James RH, Mendes V, Charoensutthivarakul S, Radoux C, Abell C, Coyne AG, Floto RA, von Delft F, Blundell TL.

Philos Trans A Math Phys Eng Sci. 2019 Jun 17;377(2147):20180422. doi: 10.1098/rsta.2018.0422.

4.

Understanding the structure and role of DNA-PK in NHEJ: How X-ray diffraction and cryo-EM contribute in complementary ways.

Wu Q, Liang S, Ochi T, Chirgadze DY, Huiskonen JT, Blundell TL.

Prog Biophys Mol Biol. 2019 Apr 20. pii: S0079-6107(18)30277-3. doi: 10.1016/j.pbiomolbio.2019.03.007. [Epub ahead of print]

PMID:
31014919
5.

The Molecular Organization of Human cGMP Specific Phosphodiesterase 6 (PDE6): Structural Implications of Somatic Mutations in Cancer and Retinitis Pigmentosa.

Maryam A, Vedithi SC, Khalid RR, Alsulami AF, Torres PHM, Siddiqi AR, Blundell TL.

Comput Struct Biotechnol J. 2019 Mar 6;17:378-389. doi: 10.1016/j.csbj.2019.03.004. eCollection 2019.

6.

Editorial.

Noble D, Blundell TL, Kohl P.

Prog Biophys Mol Biol. 2019 Jan;141:1-2. doi: 10.1016/j.pbiomolbio.2019.02.002. No abstract available.

PMID:
30902321
7.

Mycobacterial genomics and structural bioinformatics: opportunities and challenges in drug discovery.

Waman VP, Vedithi SC, Thomas SE, Bannerman BP, Munir A, Skwark MJ, Malhotra S, Blundell TL.

Emerg Microbes Infect. 2019;8(1):109-118. doi: 10.1080/22221751.2018.1561158.

8.

The deubiquitylating enzyme UCHL3 regulates Ku80 retention at sites of DNA damage.

Nishi R, Wijnhoven PWG, Kimura Y, Matsui M, Konietzny R, Wu Q, Nakamura K, Blundell TL, Kessler BM.

Sci Rep. 2018 Dec 17;8(1):17891. doi: 10.1038/s41598-018-36235-0.

9.

Progress in biophysics and molecular biology: A brief history of the journal.

Noble D, Blundell TL, Kohl P.

Prog Biophys Mol Biol. 2018 Dec;140:1-4. doi: 10.1016/j.pbiomolbio.2018.11.008. No abstract available.

PMID:
30526959
10.

Selective reduction and homologation of carbon monoxide by organometallic iron complexes.

Sharpe HR, Geer AM, Taylor LJ, Gridley BM, Blundell TJ, Blake AJ, Davies ES, Lewis W, McMaster J, Robinson D, Kays DL.

Nat Commun. 2018 Sep 14;9(1):3757. doi: 10.1038/s41467-018-06242-w.

11.

Arginine-deprivation-induced oxidative damage sterilizes Mycobacterium tuberculosis.

Tiwari S, van Tonder AJ, Vilchèze C, Mendes V, Thomas SE, Malek A, Chen B, Chen M, Kim J, Blundell TL, Parkhill J, Weinrick B, Berney M, Jacobs WR Jr.

Proc Natl Acad Sci U S A. 2018 Sep 25;115(39):9779-9784. doi: 10.1073/pnas.1808874115. Epub 2018 Aug 24.

12.

Identification of new allosteric sites and modulators of AChE through computational and experimental tools.

Roca C, Requena C, Sebastián-Pérez V, Malhotra S, Radoux C, Pérez C, Martinez A, Antonio Páez J, Blundell TL, Campillo NE.

J Enzyme Inhib Med Chem. 2018 Dec;33(1):1034-1047. doi: 10.1080/14756366.2018.1476502.

13.

Publisher Correction: Structural Implications of Mutations Conferring Rifampin Resistance in Mycobacterium leprae.

Vedithi SC, Malhotra S, Das M, Daniel S, Kishore N, George A, Arumugam S, Rajan L, Ebenezer M, Ascher DB, Arnold E, Blundell TL.

Sci Rep. 2018 May 23;8(1):8250. doi: 10.1038/s41598-018-26451-z.

14.

Dissection of DNA double-strand-break repair using novel single-molecule forceps.

Wang JL, Duboc C, Wu Q, Ochi T, Liang S, Tsutakawa SE, Lees-Miller SP, Nadal M, Tainer JA, Blundell TL, Strick TR.

Nat Struct Mol Biol. 2018 Jun;25(6):482-487. doi: 10.1038/s41594-018-0065-1. Epub 2018 May 21.

15.

Structural Implications of Mutations Conferring Rifampin Resistance in Mycobacterium leprae.

Vedithi SC, Malhotra S, Das M, Daniel S, Kishore N, George A, Arumugam S, Rajan L, Ebenezer M, Ascher DB, Arnold E, Blundell TL.

Sci Rep. 2018 Mar 22;8(1):5016. doi: 10.1038/s41598-018-23423-1. Erratum in: Sci Rep. 2018 May 23;8(1):8250.

16.

Fragment-Based Approach to Targeting Inosine-5'-monophosphate Dehydrogenase (IMPDH) from Mycobacterium tuberculosis.

Trapero A, Pacitto A, Singh V, Sabbah M, Coyne AG, Mizrahi V, Blundell TL, Ascher DB, Abell C.

J Med Chem. 2018 Apr 12;61(7):2806-2822. doi: 10.1021/acs.jmedchem.7b01622. Epub 2018 Mar 23.

17.

Editorial.

Noble D, Blundell T, Kohl P.

Prog Biophys Mol Biol. 2018 Jan;132:1-2. doi: 10.1016/j.pbiomolbio.2018.01.008. No abstract available.

PMID:
29429525
18.

TIBLE: a web-based, freely accessible resource for small-molecule binding data for mycobacterial species.

Malhotra S, Mugumbate G, Blundell TL, Higueruelo AP.

Database (Oxford). 2017 Jan 1;2017. doi: 10.1093/database/bax041.

19.

Target Identification of Mycobacterium tuberculosis Phenotypic Hits Using a Concerted Chemogenomic, Biophysical, and Structural Approach.

Mugumbate G, Mendes V, Blaszczyk M, Sabbah M, Papadatos G, Lelievre J, Ballell L, Barros D, Abell C, Blundell TL, Overington JP.

Front Pharmacol. 2017 Sep 26;8:681. doi: 10.3389/fphar.2017.00681. eCollection 2017.

20.

Protein crystallography and drug discovery: recollections of knowledge exchange between academia and industry.

Blundell TL.

IUCrJ. 2017 Jun 29;4(Pt 4):308-321. doi: 10.1107/S2052252517009241. eCollection 2017 Jul 1. Review.

21.

Decoding the similarities and differences among mycobacterial species.

Malhotra S, Vedithi SC, Blundell TL.

PLoS Negl Trop Dis. 2017 Aug 30;11(8):e0005883. doi: 10.1371/journal.pntd.0005883. eCollection 2017 Aug.

22.

Correction for Arora et al., "Respiratory Flexibility in Response to Inhibition of Cytochrome c Oxidase in Mycobacterium tuberculosis".

Arora K, Ochoa-Montaño B, Tsang PS, Blundell TL, Dawes SS, Mizrahi V, Bayliss T, Mackenzie CJ, Cleghorn LAT, Ray PC, Wyatt PG, Uh E, Lee J, Barry CE 3rd, Boshoff HI.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e01429-17. doi: 10.1128/AAC.01429-17. Print 2017 Sep. No abstract available.

23.

DNA-PKcs, Allostery, and DNA Double-Strand Break Repair: Defining the Structure and Setting the Stage.

Chirgadze DY, Ascher DB, Blundell TL, Sibanda BL.

Methods Enzymol. 2017;592:145-157. doi: 10.1016/bs.mie.2017.04.001. Epub 2017 May 3.

24.

Structural Biology and the Design of New Therapeutics: From HIV and Cancer to Mycobacterial Infections: A Paper Dedicated to John Kendrew.

Thomas SE, Mendes V, Kim SY, Malhotra S, Ochoa-Montaño B, Blaszczyk M, Blundell TL.

J Mol Biol. 2017 Aug 18;429(17):2677-2693. doi: 10.1016/j.jmb.2017.06.014. Epub 2017 Jun 23. Review.

25.

SDM: a server for predicting effects of mutations on protein stability.

Pandurangan AP, Ochoa-Montaño B, Ascher DB, Blundell TL.

Nucleic Acids Res. 2017 Jul 3;45(W1):W229-W235. doi: 10.1093/nar/gkx439.

26.

Fragment Screening against the EthR-DNA Interaction by Native Mass Spectrometry.

Chan DS, Mendes V, Thomas SE, McConnell BN, Matak-Vinković D, Coyne AG, Blundell TL, Abell C.

Angew Chem Int Ed Engl. 2017 Jun 19;56(26):7488-7491. doi: 10.1002/anie.201702888. Epub 2017 May 31.

PMID:
28513917
27.

XSuLT: a web server for structural annotation and representation of sequence-structure alignments.

Ochoa-Montaño B, Blundell TL.

Nucleic Acids Res. 2017 Jul 3;45(W1):W381-W387. doi: 10.1093/nar/gkx421.

28.

Genomes, structural biology and drug discovery: combating the impacts of mutations in genetic disease and antibiotic resistance.

Pandurangan AP, Ascher DB, Thomas SE, Blundell TL.

Biochem Soc Trans. 2017 Apr 15;45(2):303-311. doi: 10.1042/BST20160422. Review.

29.

Fragment-Sized EthR Inhibitors Exhibit Exceptionally Strong Ethionamide Boosting Effect in Whole-Cell Mycobacterium tuberculosis Assays.

Nikiforov PO, Blaszczyk M, Surade S, Boshoff HI, Sajid A, Delorme V, Deboosere N, Brodin P, Baulard AR, Barry CE 3rd, Blundell TL, Abell C.

ACS Chem Biol. 2017 May 19;12(5):1390-1396. doi: 10.1021/acschembio.7b00091. Epub 2017 Apr 5.

30.

Structural insights into the EthR-DNA interaction using native mass spectrometry.

Shiu-Hin Chan D, Seetoh WG, McConnell BN, Matak-Vinković D, Thomas SE, Mendes V, Blaszczyk M, Coyne AG, Blundell TL, Abell C.

Chem Commun (Camb). 2017 Mar 23;53(25):3527-3530. doi: 10.1039/c7cc00804j.

31.

DNA-PKcs structure suggests an allosteric mechanism modulating DNA double-strand break repair.

Sibanda BL, Chirgadze DY, Ascher DB, Blundell TL.

Science. 2017 Feb 3;355(6324):520-524. doi: 10.1126/science.aak9654. Epub 2017 Feb 2.

PMID:
28154079
32.

Structure-guided, target-based drug discovery - exploiting genome information from HIV to mycobacterial infections.

Malhotra S, Thomas SE, Ochoa Montano B, Blundell TL.

Postepy Biochem. 2016;62(3):262-272. Review.

33.

Cyclotrimerisation of isocyanates catalysed by low-coordinate Mn(ii) and Fe(ii) m-terphenyl complexes.

Sharpe HR, Geer AM, Williams HE, Blundell TJ, Lewis W, Blake AJ, Kays DL.

Chem Commun (Camb). 2017 Jan 10;53(5):937-940. doi: 10.1039/c6cc07243g.

PMID:
28008435
34.

Arpeggio: A Web Server for Calculating and Visualising Interatomic Interactions in Protein Structures.

Jubb HC, Higueruelo AP, Ochoa-Montaño B, Pitt WR, Ascher DB, Blundell TL.

J Mol Biol. 2017 Feb 3;429(3):365-371. doi: 10.1016/j.jmb.2016.12.004. Epub 2016 Dec 10.

35.

Mutations at protein-protein interfaces: Small changes over big surfaces have large impacts on human health.

Jubb HC, Pandurangan AP, Turner MA, Ochoa-Montaño B, Blundell TL, Ascher DB.

Prog Biophys Mol Biol. 2017 Sep;128:3-13. doi: 10.1016/j.pbiomolbio.2016.10.002. Epub 2016 Nov 29. Review.

36.

Targeting tuberculosis using structure-guided fragment-based drug design.

Mendes V, Blundell TL.

Drug Discov Today. 2017 Mar;22(3):546-554. doi: 10.1016/j.drudis.2016.10.003. Epub 2016 Oct 11. Review.

PMID:
27742535
37.

Different DNA End Configurations Dictate Which NHEJ Components Are Most Important for Joining Efficiency.

Chang HH, Watanabe G, Gerodimos CA, Ochi T, Blundell TL, Jackson SP, Lieber MR.

J Biol Chem. 2016 Nov 18;291(47):24377-24389. Epub 2016 Oct 4.

38.

The Inosine Monophosphate Dehydrogenase, GuaB2, Is a Vulnerable New Bactericidal Drug Target for Tuberculosis.

Singh V, Donini S, Pacitto A, Sala C, Hartkoorn RC, Dhar N, Keri G, Ascher DB, Mondésert G, Vocat A, Lupien A, Sommer R, Vermet H, Lagrange S, Buechler J, Warner DF, McKinney JD, Pato J, Cole ST, Blundell TL, Rizzi M, Mizrahi V.

ACS Infect Dis. 2017 Jan 13;3(1):5-17. doi: 10.1021/acsinfecdis.6b00102. Epub 2016 Sep 8.

39.

Engineering Archeal Surrogate Systems for the Development of Protein-Protein Interaction Inhibitors against Human RAD51.

Moschetti T, Sharpe T, Fischer G, Marsh ME, Ng HK, Morgan M, Scott DE, Blundell TL, R Venkitaraman A, Skidmore J, Abell C, Hyvönen M.

J Mol Biol. 2016 Nov 20;428(23):4589-4607. doi: 10.1016/j.jmb.2016.10.009. Epub 2016 Oct 8.

40.

Essential but Not Vulnerable: Indazole Sulfonamides Targeting Inosine Monophosphate Dehydrogenase as Potential Leads against Mycobacterium tuberculosis.

Park Y, Pacitto A, Bayliss T, Cleghorn LA, Wang Z, Hartman T, Arora K, Ioerger TR, Sacchettini J, Rizzi M, Donini S, Blundell TL, Ascher DB, Rhee K, Breda A, Zhou N, Dartois V, Jonnala SR, Via LE, Mizrahi V, Epemolu O, Stojanovski L, Simeons F, Osuna-Cabello M, Ellis L, MacKenzie CJ, Smith AR, Davis SH, Murugesan D, Buchanan KI, Turner PA, Huggett M, Zuccotto F, Rebollo-Lopez MJ, Lafuente-Monasterio MJ, Sanz O, Diaz GS, Lelièvre J, Ballell L, Selenski C, Axtman M, Ghidelli-Disse S, Pflaumer H, Bösche M, Drewes G, Freiberg GM, Kurnick MD, Srikumaran M, Kempf DJ, Green SR, Ray PC, Read K, Wyatt P, Barry CE 3rd, Boshoff HI.

ACS Infect Dis. 2017 Jan 13;3(1):18-33. doi: 10.1021/acsinfecdis.6b00103. Epub 2016 Oct 17.

41.

Virtual Screening and X-ray Crystallography Identify Non-Substrate Analog Inhibitors of Flavin-Dependent Thymidylate Synthase.

Luciani R, Saxena P, Surade S, Santucci M, Venturelli A, Borsari C, Marverti G, Ponterini G, Ferrari S, Blundell TL, Costi MP.

J Med Chem. 2016 Oct 13;59(19):9269-9275. Epub 2016 Sep 29.

PMID:
27589670
42.

Molecular Mechanism of SSR128129E, an Extracellularly Acting, Small-Molecule, Allosteric Inhibitor of FGF Receptor Signaling.

Herbert C, Schieborr U, Saxena K, Juraszek J, De Smet F, Alcouffe C, Bianciotto M, Saladino G, Sibrac D, Kudlinzki D, Sreeramulu S, Brown A, Rigon P, Herault JP, Lassalle G, Blundell TL, Rousseau F, Gils A, Schymkowitz J, Tompa P, Herbert JM, Carmeliet P, Gervasio FL, Schwalbe H, Bono F.

Cancer Cell. 2016 Jul 11;30(1):176-178. doi: 10.1016/j.ccell.2016.06.015. Epub 2016 Jul 11. No abstract available.

43.

ATP half-sites in RadA and RAD51 recombinases bind nucleotides.

Marsh ME, Scott DE, Ehebauer MT, Abell C, Blundell TL, Hyvönen M.

FEBS Open Bio. 2016 Apr 6;6(5):372-85. doi: 10.1002/2211-5463.12052. eCollection 2016 May.

44.
45.

Identifying Interactions that Determine Fragment Binding at Protein Hotspots.

Radoux CJ, Olsson TS, Pitt WR, Groom CR, Blundell TL.

J Med Chem. 2016 May 12;59(9):4314-25. doi: 10.1021/acs.jmedchem.5b01980. Epub 2016 Apr 11.

PMID:
27043011
46.

Structure-activity relationship of the peptide binding-motif mediating the BRCA2:RAD51 protein-protein interaction.

Scott DE, Marsh M, Blundell TL, Abell C, Hyvönen M.

FEBS Lett. 2016 Apr;590(8):1094-102. doi: 10.1002/1873-3468.12139. Epub 2016 Apr 6.

47.

A fragment merging approach towards the development of small molecule inhibitors of Mycobacterium tuberculosis EthR for use as ethionamide boosters.

Nikiforov PO, Surade S, Blaszczyk M, Delorme V, Brodin P, Baulard AR, Blundell TL, Abell C.

Org Biomol Chem. 2016 Feb 21;14(7):2318-26. doi: 10.1039/c5ob02630j. Epub 2016 Jan 25.

49.

Structure of BRCA1-BRCT/Abraxas Complex Reveals Phosphorylation-Dependent BRCT Dimerization at DNA Damage Sites.

Wu Q, Paul A, Su D, Mehmood S, Foo TK, Ochi T, Bunting EL, Xia B, Robinson CV, Wang B, Blundell TL.

Mol Cell. 2016 Feb 4;61(3):434-448. doi: 10.1016/j.molcel.2015.12.017. Epub 2016 Jan 14.

50.

Developing Antagonists for the Met-HGF/SF Protein-Protein Interaction Using a Fragment-Based Approach.

Winter A, Sigurdardottir AG, DiCara D, Valenti G, Blundell TL, Gherardi E.

Mol Cancer Ther. 2016 Jan;15(1):3-14. doi: 10.1158/1535-7163.MCT-15-0446. Epub 2015 Dec 28.

Supplemental Content

Loading ...
Support Center